Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01616576 · ClinicalTrials.gov registry record · NA
Evaluation of a HiRes™ Optima Sound Processing Strategy for the HiResolution™ Bionic Ear
A NA study, sponsored by Advanced Bionics.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01616576: Completed NA study, sponsored by Advanced Bionics.
NCT01616576 is a NA study that has completed, run by Advanced Bionics. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01616576, a NA study, has completed, sponsored by Advanced Bionics.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to compare a new sound processing strategy to the current sound processing strategy.
Primary Outcome
Sentence recognition with the new (experimental) and current (control) sound processing strategies will be compared. Subjects will be tested using the AzBio corpus of sentences, which consists of 33 lists of 20 sentences each (6 to 10 words per sentence) that are equated for intelligibility. The difference between the Control percent correct scores and Experimental percent correct scores will be used for the analysis (Experimental AzBio scores minus Control AzBio scores). Data from both Group A
Interventions
- DEVICE Control first, then Experimental
- DEVICE Experimental first, then Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT01616576 record still lists
NCT01616576 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Control first, then Experimental is the first listed.
NCT01616576 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01616576 about?
NCT01616576 is a clinical study titled "Evaluation of a HiRes™ Optima Sound Processing Strategy for the HiResolution™ Bionic Ear". The purpose of this study is to compare a new sound processing strategy to the current sound processing strategy.
What is the current status of trial NCT01616576?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2012-05. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01616576?
The interventions under investigation include: Control first, then Experimental (DEVICE), Experimental first, then Control (DEVICE).
Who is sponsoring clinical trial NCT01616576?
This trial is sponsored by Advanced Bionics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01616576's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia